İÇ HASTALIKLARI Dergisi 2010; 17: 183-188
KAYNAKLAR

"Ulusal Venöz Tromboembolizm Profilaksi ve
Tedavi Kılavuzu-2010" Hazırlığında
Yararlanılan Kılavuzlar

Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke (AHA/ASA guideline). Stroke 2007;38:1655-1711. [Özet] [Tam Metin] [PDF]

Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:630S-669S. [Özet] [Tam Metin] [PDF]

American Academy of Orthopaedic Surgeons Board of Directors. American Academy of Orthopaedic Surgeons Clinical Guideline on the Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Artroplasty. 2007.

Arseven O, Sevinç C, Alataş F, Ekim N, Erkan L, Fındık S ve ark. Türk Toraks Derneği Pulmoner Tromboembolizm Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2009;10(Ek 11):1-46.

Bates SM, Greer IA, Papinger I, Sofaer S, Hirsch J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008;133:844S-886S. [Özet] [Tam Metin] [PDF]

Bozkurt AK, Demirkılıç U, Topçuoğlu Ş, Gürbüz A, Yazıcıoğlu L, Küçüker ŞA ve ark. Türk Kalp Damar Cerrahisi Derneği. Periferik Arter ve Ven Hastalıkları Tedavi Kılavuzu - 2008. Öncü Basımevi. 2008, Ankara.

Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007;197(5):457:e1-21. [Özet]

Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) prevention of venous thromboembolism. Chest 2008;133:381S-453S. [Özet] [Tam Metin] [PDF]

Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic Therapy for Venous Thromboembolic Disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133;454-545.
[Özet] [Tam Metin] [PDF]

Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M,  et al. American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. JCO 2007;25:5490-5505. [Özet] [Tam Metin] [PDF]

Mandala M, Falanga A, Roila F. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management. Ann Oncol 2010;21(Suppl 5):274-276. [Tam Metin] [PDF]

National Clinical Guideline Centre - Acute and Chronic Conditions (formerly the National Collaborating Centre for Acute Care). Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. London, 2009.

NCCN Clinical Practice Guidelines in Oncology. Venous Thromboembolic Disease. V.1.2010

Nicolaides AN, Fareed J, Kakkar AK, Breddin HK, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol 2006;25(2):101-161.

The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008;25:457-507.
[Özet] [PDF]

The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008;29:2276-2315. [Özet] [Tam Metin] [PDF]

Venturi ML, Davidson SP, Caprini JA. Prevention of venous thromboembolism in the plastic surgery patient: Current guidelines and recommendations. Aest Surg J 2009;29(5):421-431. [Özet]

  1. Segal JB, Eng J, Janckes MW, Tamariz LJ, Bolger DT, Krishnan JA, et al. Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Agency for Healthcare Research and Quality Publication No. 03-E016,2003:1-169.
  2. Ho WK, Hankey GJ, Lee CH, Eikelboom JW. Venous thromboembolism: diagnosis and management of deep venous thrombosis. MJA 2005;182:476-481. [Özet]
  3. Devecioğlu Ö, Dündar S, Demir M, Karadoğan İ (Eds). Tromboz El Kitabı. Türk Hematoloji Derneği Yayınları 2004, Ankara.
  4. Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med 2004;10:356-365. [Özet]
  5. Cooper WJ, Groce III J. Advances in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Consult Pharm 2001;16(Suppl D):7-17.
  6. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) prevention of venous thromboembolism. Chest 2008;133:381S-453S. [Özet] [Tam Metin] [PDF]
  7. Cohen AT, Tapson DF, Bergmann J-F, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-394. [Özet]
  8. Arseven O, Sevinç C, Alataş F, Ekim N, Erkan L, Fındık S ve ark. Türk Toraks Derneği Pulmoner Tromboembolizm Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2009;10(Ek 11):1-46.
  9. Bozkurt AK, Demirkılıç U, Topçuoğlu Ş, Gürbüz A, Yazıcıoğlu L, Küçüker ŞA ve ark. Türk Kalp Damar Cerrahisi Derneği. Periferik Arter ve Ven Hastalıkları Tedavi Kılavuzu - 2008. Öncü Basımevi. 2008, Ankara.
  10. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008;29:2276-2315. [Özet] [Tam Metin] [PDF]
  11. Ongen G, Yılmaz A, Cirak AK, Ersoy CY, Erden F, Altıntas F, et al. Venous thromboembolism risk and thromboprophylaxis among hospitalized patients: data from the Turkish arm of the ENDORSE study. Clin Appl Thromb/Hemost 2010, e-pub.
  12. Kurtoğlu M. An observational study for VTE risk assessment among hospitalized patients in general surgery clinics across Turkey (basımda).
  13. Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007;197(5):457:e1-e21.
    [Özet]
  14. Demir M, Kurtoglu M. Yeni antikoagülanlar. Fleboloji Dergisi 2009;11(3):73-76.
  15. Demir M. Derin Ven Trombozunun İdeal Tedavisi Nasıl Olmalıdır? Ed: Bozkurt K, Yıldırım M. Kronik venöz yetersizlik. Nobel Tıp Kitabevleri İstanbul, 2007 ss. 71-80. ISBN: 978-975-420-557-2.
  16. Modern İlaç Rehberi, 2010. Medical Tribune Yayıncılık. Ankara.
  17. Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 2005;94:750-759. [Özet]
  18. Kurtoğlu M, Öztürk A. Venöz tromboembolizmin profilaksisi. Turkiye Klinikleri J Gen Surg-Special Topics 2008;1(1):29-38. [Özet]
  19. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;26:338S-400S. [Özet] [Tam Metin] [PDF]
  20. Caprini JA. Venous thromboembolism risk factor assessment. www.med.umich.edu/clinical/images/VTERiskAssessment.pdf, 1.5.2007.
  21. İ.Ü. İstanbul Tıp Fakültesi Genel Cerrahi Anabilim Dalı. DVT Profilaksisi Risk Değerlendirme Formu, 2009.
  22. Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007;92:3006-3012. [Özet] [Tam Metin] [PDF]
  23. Squizzato A, Romualdi E, Piantanida E, Gerdes VE, Büller HR, Tanda M, et al. Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost 2007;97(5):803-806. [Özet]
  24. Venturi ML, Davidson SP, Caprini JA. Prevention of venous thromboembolism in the plastic surgery patient: current guidelines and recommendations. Aest Surg J 2009;29(5):421-431. [Özet]
  25. 22nd Annual Meeting of the American Venous Forum (AVF), 2010, Amelia Island, FL, ABD.
  26. Taniguchi S, Fukuad I, Daitoku K, Minakawa M, Odagiri S, Suzuki Y, et al. Prevalence of venous thromboembolism in neurosurgical patients. Heart Vessels 2009;24:425-428. [Özet]
  27. Nicolaides AN, Fareed J, Kakkar AK, Breddin HK, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol 2006;25(2):101-161.
  28. Salman MC, Durukan B, Deren Ö, Durukan T. Jinekolojide tromboz profilaksisi. Turk Jinekol Obstet Der2005;2(5):31-36. [PDF]
  29. Greer IA. Venous thromboembolism and anticoagulant therapy in pregnancy. Gend Med 2005;2(Suppl A):10-17. [Özet]
  30. Narin C, Reyhanoğlu H, Tülek B, Onoglu R, Ege E, Sarıgül A, et al. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Adv Ther 2008;25(6):585-594.
    [Özet]
  31. Bates SM, Greer IA, Papinger I, Sofaer S, Hirsch J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008;133:844S-886S. [Özet] [Tam Metin] [PDF]
  32. Montavon C, Hoesli I, Holzgreve W, Tsakiris DA. Thrombophilia and anticoagulation in pregnancy: indications, risks and management. J Matern Fetal Neonatal Med 2008;21(10):685-696. [Özet]
  33. İsbir S. Venöz Tromboemboli Prolifaksisi: Güncel Kılavuz Bilgileri. İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. Sempozyum Dizisi 2007;56:57-70.
  34. Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009;7(1):58-64. [Özet] [Tam Metin] [PDF]
  35. Ni Ainle F, Wong A, Appleby N, Byrne B, Regan C, Hassan T, et al. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy. Blood Coagul Fibrinolysis 2008;19(7):689-692. [Özet]
  36. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J, the LIVE-ENOX investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Hemost 2005;3:227-229. [Tam Metin] [PDF]
  37. Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akashet H, et al. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Human Fertility 2008;11(4):246-253. [Özet]
  38. Geerts WH, Code KI, Joy RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601-1606. [Özet] [Tam Metin] [PDF]
  39. Knudson MM, Collins JA, Goodman SB, McCrory DW. Thromboembolism following multiple trauma. J Trauma 1992;32:2-11. [Özet]
  40. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report; part I. Analysis of risk factors and evaluation of the role of vena caval filters. J Trauma 2000;49:132-139. [Özet]
  41. Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA, Hamilton PA. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335:701-707. [Özet] [Tam Metin] [PDF]
  42. Cothren CC, Smith WR, Moore EE, Morgan SJ. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg 2007;31:98-104. [Özet]
  43. Serin K, Yanar H, Özdenkaya Y, Tuğrul S, Kurtoğlu M. Venous thromboembolism prophylaxis methods in trauma and emergency surgery intensive care unit patients: low molecular weight heparin versus elastic stockings + intermittent pneumatic compression. Ulus Travma Derg 2010;16(2):130-134.
    [Özet] [PDF]
  44. Kurtoglu M, Yanar H, Bilsel Y, Guloglu R, Kizilirmak S, Buyukkurt D, Granit V. Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight Heparin. World J Surg 2004;28:807-811. [Özet] [Tam Metin] [PDF]
  45. Altıntaş F, Gürbüz H, Erdemli B, Atilla B, Ustaoğlu RG, Oziç U ve ark. Majör ortopedik cerrahilerde venöz tromboemboli profilaksisi: Çok merkezli, prospektif, gözlem çalışması. Acta Orthop Traumatol Turc 2008;42(5): 322-327. [Özet] [PDF]
  46. American Academy of Orthopaedic Surgeons Board of Directors. American Academy of Orthopaedic Surgeons Clinical Guideline on the Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Artroplasty. 2007.
  47. TOTBİD VTE Değerlendirme Formu, www.totbid.org, 2010.
  48. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874-879. [Özet] [Tam Metin] [PDF]
  49. Samama MM, Cohen AT, Darmon J-Y, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800. [Özet] [Tam Metin] [PDF]
  50. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. Fondaparinux for the prevention of VTE in acutely ill medical patients. Blood 2003;102:42A.
  51. Haas SK. Venous thromboembolic risk and its prevention in hospitalized medical patients. Semin Thromb Hemost 2002;28(6):577-584. [Özet]
  52. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006;332(7537):325-329. [Özet] [Tam Metin] [PDF]
  53. NCCN Clinical Practice Guidelines in Oncology. Venous Thromboembolic Disease. V.1.2010.
  54. Mandala M, Falanga A, Roila F. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management. Ann Oncol 2010;21(Suppl 5):274-276. [Tam Metin] [PDF]
  55. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M,  et al. American Society of Clinical Oncology Guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. JCO 2007;25:5490-5505. [Özet] [Tam Metin] [PDF]
  56. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke (AHA/ASA guideline). Stroke 2007;38:1655-1711.
    [Özet] [Tam Metin] [PDF]
  57. Elias A, Milandre L, Lagrange G, Aillaud MF, Alonzo B, Toulemonde F, et al. Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients). Rev Med Intern 1990;11:95-98. [Özet]
  58. Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJ. Prophylaxis of deep venous thrombosis with a low-molecular-weight-heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis 1989;19:245-250. [Özet]
  59. Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Semin Thromb Hemost 1990;16 Suppl:25-33. [Özet]
  60. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008;25:457-507. [Özet] [PDF]
  61. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007;369:1347-1355.
    [Özet]
  62. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:630S-669S. [Özet] [Tam Metin] [PDF]
  63. McGarry LJ, Stokes ME, Thompson D. Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients Thrombosis Journal 2006;4(17):1-9.
  64. National Clinical Guideline Centre - Acute and Chronic Conditions (formerly the National Collaborating Centre for Acute Care). Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. London, 2009.
  65. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic Therapy for Venous Thromboembolic Disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133;454-545. [Özet] [Tam Metin] [PDF]
  66. Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin Oncol 2009;27(29):4848-57. [Özet]
  67. Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009;113:3911-3917.
    [Özet] [Tam Metin]
  68. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006;24(3):484-90. [Özet]
  69. Demir M. Dahili hastalıklar grubunda venöz tromboembolizm oluşumunun engellenmesi (tromboproflaksi). Prospect 2003;5(2):34-38.
  70. Zhu T, Martinez I, Emmerich I. Venous thromboembolism: risk factors for recurrence. Arterioscler Vasc Biol 2009;29:298-310. [Özet] [Tam Metin] [PDF]
  71. Van Dongen CJJ, van der Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2004.
  72. Kurtoğlu M. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial. Journal of Vascular Surgery 2010 Aug 21, e-pub.
  73. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004; CD002783. [Özet]
  74. Demir M, Öztürk E. Kan sulandırıcılarına bağlı kanamalar. Ed: Ertekin C, Güloğlu R, Taviloğlu K. Acil Cerrahi. Nobel Tıp Kitabevleri İstanbul, 2009 ss. 667-75. ISBN: 978-9944-5104-2-4.

Yazdır